Alx Oncology Holdings Inc (NASDAQ: ALXO) on Friday, soared 3.34% from the previous trading day, before settling in for the closing price of $5.84. Within the past 52 weeks, ALXO’s price has moved between $3.94 and $17.83.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -8.67% over the last five years. The company achieved an average annual earnings per share of 24.01%. With a float of $29.77 million, this company’s outstanding shares have now reached $49.95 million.
The firm has a total of 72 workers. Let’s measure their productivity.
Alx Oncology Holdings Inc (ALXO) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Alx Oncology Holdings Inc is 42.86%, while institutional ownership is 56.42%. The most recent insider transaction that took place on Jun 13 ’24, was worth 102,338. In this transaction CHIEF FINANCIAL OFFICER of this company bought 12,000 shares at a rate of $8.53, taking the stock ownership to the 122,348 shares. Before that another transaction happened on Jun 04 ’24, when Company’s PRESIDENT & CSO sold 20,000 for $8.43, making the entire transaction worth $168,652. This insider now owns 604,205 shares in total.
Alx Oncology Holdings Inc (ALXO) Recent Fiscal highlights
As on 3/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.84 earnings per share (EPS) for the period topping the consensus outlook (set at -0.88) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.71 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 24.01% per share during the next fiscal year.
Alx Oncology Holdings Inc (NASDAQ: ALXO) Trading Performance Indicators
Alx Oncology Holdings Inc (ALXO) is currently performing well based on its current performance indicators. A quick ratio of 5.21 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.71, a number that is poised to hit -0.74 in the next quarter and is forecasted to reach -2.81 in one year’s time.
Technical Analysis of Alx Oncology Holdings Inc (ALXO)
Analysing the last 5-days average volume posted by the [Alx Oncology Holdings Inc, ALXO], we can find that recorded value of 1.67 million was better than the volume posted last year of 0.59 million. As of the previous 9 days, the stock’s Stochastic %D was 10.59%. Additionally, its Average True Range was 0.80.
During the past 100 days, Alx Oncology Holdings Inc’s (ALXO) raw stochastic average was set at 3.91%, which indicates a significant decrease from 13.75% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 56.82% in the past 14 days, which was lower than the 88.12% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.25, while its 200-day Moving Average is $11.47. Now, the first resistance to watch is $6.31. This is followed by the second major resistance level at $6.59. The third major resistance level sits at $6.97. If the price goes on to break the first support level at $5.65, it is likely to go to the next support level at $5.27. Now, if the price goes above the second support level, the third support stands at $4.99.
Alx Oncology Holdings Inc (NASDAQ: ALXO) Key Stats
Market capitalization of the company is 314.16 million based on 52,100K outstanding shares. Right now, sales total 0 K and income totals -160,810 K. The company made 0 K in profit during its latest quarter, and -35,580 K in sales during its previous quarter.
